New MIMS table summarises monitoring requirements for lipid-lowering drugs

GPs can now use a handy MIMS table to check which tests are needed for patients taking statins or other hyperlipidaemia treatments.

by Chloe Harman
Patients taking lipid-lowering drugs may need to be monitored for signs of myopathy and rhabdomyolysis.
Patients taking lipid-lowering drugs may need to be monitored for signs of myopathy and rhabdomyolysis.

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package